Follow last change Aug 2025 re-read 3 minutes ago

ADSC

also known as ASC

Developed for: osteoarthritis
Investigated by: Aries srl (ARIES) · Assistance Publique - Hôpitaux de Paris · Cambridge University Hospitals NHS Foundation Trust · Centre National de la Recherche Scientifique, France · EVANGELISCHES WALDKRANKENHAUS SPANDAU KRANKENHAUSBETRIEBS GGMBH (EWK) · Etablissement Français du Sang
+12 more
· European Clinical Research Infrastructure Network · French National Institute of Health and Medical Research · HUMAN MED AG (HM) · National University of Ireland, Galway, Ireland · PINTAIL LTD (PT) · Rizzoli Orthopaedic Institute · SPORTS SURGERY CLINIC LIMITED · Stichting Katholieke Universiteit · University Hospital, Montpellier · University Hospital, Toulouse · University of Padova · University of Ulm

today NCT02838069 · Ph 2

20172018201920202021202220232024202520262027

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 2	NCT02838069	Sep 2016 → Sep 2022	osteoarthritis	University Hospital, Montpellier	Completed	Missed primary

Every value below carries the sentence it was read from. 2 sources stand behind the page.

Field	Value	Cited text
Known as	ADSC	“This study aims to evaluate the efficacy of intra-articular autologous adipose-derived ex vivo expanded mesenchymal stromal cells (ADSC) on patient-reported outcome (pain and...” PMID 40885690 ↗ Aug 2025
Known as	ASC	“Injection of Autologous adipose derived stem cells (2x106 ASC/5ml).” NCT02838069 ↗
Modality	Cell therapy	“Autologous adipose derived stem cells” NCT02838069 ↗
Route	Other	“ASCs will be administered via intra-articular use into the knee joint affected by OA” NCT02838069 ↗